2003
Prognostic Factors for Metastatic Kidney Cancer
Drucker BJ, Mazumdar M, Motzer RJ. Prognostic Factors for Metastatic Kidney Cancer. Cancer Treatment And Research 2003, 116: 139-153. PMID: 14650830, DOI: 10.1007/978-1-4615-0451-1_8.Peer-Reviewed Original ResearchConceptsResponse rateMetastatic renal cell carcinomaStudy of immunotherapyEffective systemic therapyMetastatic kidney cancerStandard cytotoxic chemotherapyRenal cell cancerSpontaneous tumor regressionRenal cell carcinomaSignificant antitumor effectHormonal therapyUntreated patientsCytotoxic chemotherapyHormone therapyMetastatic RCCSystemic therapyPrognostic factorsCell cancerLymphocytic infiltrationPoor prognosisCell carcinomaRenal tumorsTumor regressionKidney cancerAntitumor effects
2002
Prognostic factors for biologic therapy in kidney cancer
Drucker BJ. Prognostic factors for biologic therapy in kidney cancer. Current Urology Reports 2002, 3: 31-36. PMID: 12084217, DOI: 10.1007/s11934-002-0008-5.Peer-Reviewed Original ResearchConceptsPrior nephrectomyCytokine therapyPrognostic factorsGood performance statusNormal lactate dehydrogenaseMajority of patientsLevels of cytokinesPresence of eosinophilsRenal cell cancerSubpopulations of lymphocytesLack of anemiaBiologic therapyPerformance statusImproved survivalCell cancerDisease characteristicsTumor responseNormal calciumImmune parametersInterleukin-2Kidney cancerTherapeutic benefitResponse rateTherapyLactate dehydrogenase